Search by Drug Name or NDC

    NDC 68180-0185-01 Mefenamic Acid 250 mg/1 Details

    Mefenamic Acid 250 mg/1

    Mefenamic Acid is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is MEFENAMIC ACID.

    Product Information

    NDC 68180-0185
    Product ID 68180-185_8b5a92b7-2f16-4ed0-adc7-4d6ec0baaaf8
    Associated GPIs 66100050000105
    GCN Sequence Number 004285
    GCN Sequence Number Description mefenamic acid CAPSULE 250 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 16530
    HICL Sequence Number 001776
    HICL Sequence Number Description MEFENAMIC ACID
    Brand/Generic Generic
    Proprietary Name Mefenamic Acid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Mefenamic Acid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name MEFENAMIC ACID
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091322
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0185-01 (68180018501)

    NDC Package Code 68180-185-01
    Billing NDC 68180018501
    Package 100 CAPSULE in 1 BOTTLE (68180-185-01)
    Marketing Start Date 2011-09-06
    NDC Exclude Flag N
    Pricing Information N/A